Skip to main content
. 2016 May;13(5):627–635. doi: 10.1513/AnnalsATS.201510-719OC

Figure 2.

Figure 2.

A physiologic pattern of FVC loss at chronic lung allograft dysfunction (CLAD) onset was associated with worse post-CLAD survival among bilateral recipients at University of California at Los Angeles (UCLA) (P = 0.001) (A), similar to what has been previously described. Among single lung recipients, FVC loss was also associated with worse post-CLAD survival (P = 0.02) (B). DUMC = Duke University Medical Center.